ResMed Inc (RMD)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$243.00

Buy

$249.70

arrow-down$-1.40 (-0.57%)

Prices updated at 18 Dec 2025, 00:21 EST
| Prices minimum 15 mins delay
|
Prices in USD

ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders.

Income statement

20242025
4,685m5,146m
2,655m3,055m
1,384m1,687m
29.5432.79
1,021m1,401m
1,600m1,923m
Sales, General and administrative917m991m
Interest expenses--
Provision for income taxes244m277m
Operating expenses1,271m1,368m
Income before taxes1,265m1,678m
Net income available to common shareholders1,021m1,401m
8.59.81
Net interest income-46m4m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)8.479.77
Free cash flow per share9.126811.936
Book value/share35.374941.9361
Debt equity ratio0.172440.135963

Balance sheet

20242025
Current assets2,358m3,506m
Current liabilities911m1,019m
Total capital5,561m6,626m
Total debt874m852m
Total equity4,864m5,968m
Total non current liabilities--
Loans697m658m
Total assets6,872m8,174m
Total liabilities--
Cash and cash equivalents238m1,209m
Common stock147m146m

Cash flow

20242025
Cash at beginning of period228m238m
Cash dividends paid-282m-311m
1,286m1,651m
Investments (gains) losses-270m-200m
238m1,209m
Net income--
1,401m1,752m
-115m-101m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.